TaiwanJ Pharmaceuticals Co., Ltd. (6549) Stock Price & Analysis

6549 Stock Chart & Stats

NT$6.04-NT$0.21(-3.36%)

At close: Nov 06 1:57 AM EST

Day’s Range: TWD 5.37 - TWD 6.15
52-Week Range: TWD 5.37 - TWD 9.80
Previous Close: TWD 6.25
Volume: N/A
Average Volume (3M): 67.00K
Market Cap: TWD 483.94M
Enterprise Value: N/A
Total Cash (Recent Filing): TWD 60.17M
Total Debt (Recent Filing): TWD 2.07M
Price to Earnings (P/E): ―
Beta: 0.44
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

6549 FAQ

What was TaiwanJ Pharmaceuticals Co., Ltd.’s price range in the past 12 months?

TaiwanJ Pharmaceuticals Co., Ltd. lowest stock price was TWD 5.37 and its highest was TWD 9.80 in the past 12 months.

What is TaiwanJ Pharmaceuticals Co., Ltd.’s market cap?

TaiwanJ Pharmaceuticals Co., Ltd.’s market cap is TWD 483.94M.

When is TaiwanJ Pharmaceuticals Co., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is TaiwanJ Pharmaceuticals Co., Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does TaiwanJ Pharmaceuticals Co., Ltd. pay dividends?

TaiwanJ Pharmaceuticals Co., Ltd. does not currently pay dividends.

What is TaiwanJ Pharmaceuticals Co., Ltd.’s EPS estimate?

TaiwanJ Pharmaceuticals Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TaiwanJ Pharmaceuticals Co., Ltd. have?

TaiwanJ Pharmaceuticals Co., Ltd. has 80,122,000 shares outstanding.

Which hedge fund is a major shareholder of TaiwanJ Pharmaceuticals Co., Ltd.?

Currently, no hedge funds are holding shares in TW:6549

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	6	2	14
Technical Analysis	6	2	2
Moving Averages	0	0	12

Technical Analysis >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft